2026 Q2 Portfolio Activity
In 2026 Q2, Nantahala Capital Management, LLC maintained a portfolio of 179 distinct positions. The most significant new addition was ETF SER SOLUTIONS, now representing 1.23% of the total fund value. They heavily accumulated shares in BANCORP INC DEL, increasing the position by 885.6%. The fund also reduced its exposure to HERBALIFE LTD by 80.2%.
Position History
hover any row below to update
Loading…
Total Positions
179
Quarter
2026 Q2
Top Holding
IWM (20.0%)
Top 10 Concentration
41.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 179
Nantahala Capital Management, LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
IWM
PUT
ISHARES TR
|
PUT Option | 20.00% | 18.72% |
#1
Prev: #1
|
6.5 |
—
|
-50,000 | -2.4% |
P
S
|
2,000,000 | $600,900,000 | 2012 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PTON
CALL
PELOTON INTERAC...
|
CALL Option | 3.23% | 2.83% |
#2
1
Prev: #3
|
3.3 |
—
|
-1,500,000 | -8.4% |
P
S
|
16,438,900 | $97,153,899 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HLF
CALL
HERBALIFE LTD
|
CALL Option | 2.89% | 3.03% |
#3
1
Prev: #2
|
4.2 |
—
|
1,000,000 | 17.9% |
P
S
|
6,600,000 | $86,790,000 | 2012 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VTRS
CALL
VIATRIS INC
|
CALL Option | 2.64% | 2.49% |
#4
1
Prev: #5
|
2.6 |
—
|
no change | no change |
P
S
|
5,000,000 | $79,400,000 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TBBK
BANCORP INC DEL
|
Financial Services | 2.59% | 2.73% |
#5
1
Prev: #4
|
2.0 |
—
|
-140,569 | -10.2% |
P
S
|
1,239,887 | $77,666,522 | 2014 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EW
PUT
EDWARDS LIFESCI...
|
PUT Option | 2.41% | 2.36% |
#6
Prev: #6
|
2.0 |
—
|
no change | no change |
P
S
|
800,000 | $72,368,000 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 2.11% | 1.41% |
#7
9
Prev: #16
|
3.3 |
—
|
100,000 | 33.3% |
P
S
|
400,000 | $63,300,000 | 2014 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BVS
BIOVENTUS INC
|
Healthcare | 1.89% | 2.06% |
#8
1
Prev: #9
|
1.3 |
—
|
-122,124 | -2.0% |
P
S
|
6,000,279 | $56,642,634 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HGV
CALL
HILTON GRAND VA...
|
CALL Option | 1.87% | 1.55% |
#9
5
Prev: #14
|
1.7 |
—
|
no change | no change |
P
S
|
1,075,000 | $56,297,750 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HGV
HILTON GRAND VA...
|
Consumer Cyclical | 1.80% | 2.18% |
#10
3
Prev: #7
|
0.7 |
—
|
-480,486 | -31.7% |
P
S
|
1,033,170 | $54,107,113 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SVRA
SAVARA INC
|
Healthcare | 1.43% | 1.48% |
#11
4
Prev: #15
|
1.1 |
—
|
-367,973 | -5.0% |
P
S
|
6,976,810 | $42,977,150 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ETON
ETON PHARMACEUT...
|
Healthcare | 1.42% | 1.07% |
#12
10
Prev: #22
|
1.6 |
—
|
no change | no change |
P
S
|
1,175,951 | $42,569,426 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AMRX
AMNEAL PHARMACE...
|
Healthcare | 1.31% | 1.30% |
#13
6
Prev: #19
|
0.5 |
—
|
-575,357 | -20.2% |
P
S
|
2,268,751 | $39,272,080 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EOLS
EVOLUS INC
|
Healthcare | 1.29% | 0.96% |
#14
9
Prev: #23
|
1.0 |
—
|
-774,836 | -12.2% |
P
S
|
5,602,021 | $38,878,026 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QTUM
PUT
ETF SER SOLUTIO...
|
PUT Option | 1.23% | — |
#15
Prev: #—
|
4.0 |
—
|
223,000 | — |
NEW
|
223,000 | $36,879,740 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QURE
CALL
UNIQURE NV
|
CALL Option | 1.23% | 1.56% |
#16
3
Prev: #13
|
0.5 |
—
|
-1,800,000 | -69.2% |
P
S
|
800,000 | $36,848,000 | 2016 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 1.15% | 0.68% |
#17
24
Prev: #41
|
3.5 |
—
|
627,250 | 50.8% |
P
S
|
1,862,250 | $34,414,380 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 1.14% | 0.96% |
#18
7
Prev: #25
|
1.5 |
—
|
no change | no change |
P
S
|
1,052,894 | $34,171,675 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NBIX
CALL
NEUROCRINE BIOS...
|
CALL Option | 1.12% | — |
#19
Prev: #—
|
3.9 |
—
|
200,000 | — |
NEW
|
200,000 | $33,707,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PRAX
PUT
PRAXIS PRECISIO...
|
PUT Option | 1.11% | — |
#20
Prev: #—
|
3.9 |
—
|
100,000 | — |
NEW
|
100,000 | $33,479,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVR
ANTERIS TECHNOL...
|
Healthcare | 1.11% | 1.13% |
#21
Prev: #21
|
0.4 |
—
|
-2,147,575 | -38.8% |
P
S
|
3,383,335 | $33,325,850 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABEO
ABEONA THERAPEU...
|
Healthcare | 1.06% | 0.83% |
#22
11
Prev: #33
|
0.9 |
—
|
123,438 | 2.5% |
P
S
|
5,136,490 | $31,743,508 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KRYS
PUT
KRYSTAL BIOTECH...
|
PUT Option | 1.05% | — |
#23
Prev: #—
|
3.9 |
—
|
85,000 | — |
NEW
|
85,000 | $31,591,950 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PTON
PELOTON INTERAC...
|
Consumer Cyclical | 1.01% | 1.90% |
#24
14
Prev: #10
|
0.4 |
—
|
-6,891,005 | -57.4% |
P
S
|
5,108,995 | $30,194,160 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ESTA
ESTABLISHMENT L...
|
Healthcare | 0.96% | 1.74% |
#25
14
Prev: #11
|
0.4 |
—
|
-497,126 | -59.7% |
P
S
|
335,830 | $28,817,572 | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XTNT
XTANT MED HLDGS...
|
Healthcare | 0.96% | 1.40% |
#26
9
Prev: #17
|
1.4 |
—
|
no change | no change |
P
S
|
68,394,000 | $28,793,874 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JACK
JACK IN THE BOX...
|
Consumer Cyclical | 0.91% | 0.55% |
#27
23
Prev: #50
|
2.4 |
—
|
185,944 | 12.1% |
P
S
|
1,728,659 | $27,330,099 | 2012 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GOGO
GOGO INC
|
Communication Services | 0.90% | 1.31% |
#28
10
Prev: #18
|
0.9 |
—
|
-184,305 | -2.1% |
P
S
|
8,697,731 | $26,962,966 | 2022 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMAX
IMAX CORP
|
Communication Services | 0.87% | 0.72% |
#29
9
Prev: #38
|
2.8 |
—
|
142,455 | 27.6% |
P
S
|
658,009 | $26,228,239 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZVRA
ZEVRA THERAPEUT...
|
Healthcare | 0.86% | 0.87% |
#30
1
Prev: #29
|
0.3 |
—
|
-724,460 | -28.7% |
P
S
|
1,797,476 | $25,775,806 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
REGN
CALL
REGENERON PHARM...
|
CALL Option | 0.83% | 1.14% |
#31
11
Prev: #20
|
1.3 |
—
|
no change | no change |
P
S
|
40,000 | $24,941,600 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TITN
TITAN MACHY INC
|
Industrials | 0.80% | 0.77% |
#32
4
Prev: #36
|
0.8 |
—
|
-121,432 | -9.7% |
P
S
|
1,133,088 | $23,930,819 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RMR
RMR GROUP INC
|
Real Estate | 0.78% | 0.65% |
#33
9
Prev: #42
|
1.3 |
—
|
no change | no change |
P
S
|
1,147,902 | $23,566,428 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
FOSL
FOSSIL GROUP IN...
|
Consumer Cyclical | 0.76% | 0.86% |
#34
3
Prev: #31
|
0.8 |
—
|
101,104 | 1.9% |
P
S
|
5,505,128 | $22,791,230 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
FOXF
FOX FACTORY HLD...
|
Consumer Cyclical | 0.74% | 0.90% |
#35
8
Prev: #27
|
0.8 |
—
|
-177,605 | -11.9% |
P
S
|
1,310,695 | $22,209,727 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 0.74% | 0.89% |
#36
8
Prev: #28
|
0.8 |
—
|
-75,000 | -8.4% |
P
S
|
820,481 | $22,136,577 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RMBL
RIDENOW GROUP I...
|
Unknown | 0.73% | 0.85% |
#37
5
Prev: #32
|
1.3 |
—
|
no change | no change |
P
S
|
3,272,845 | $21,797,148 | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SNAP
CALL
SNAP INC
|
CALL Option | 0.71% | — |
#38
Prev: #—
|
3.8 |
—
|
4,800,000 | — |
NEW
|
4,800,000 | $21,312,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QURE
UNIQURE NV
|
Healthcare | 0.70% | 0.14% |
#39
69
Prev: #108
|
3.3 |
—
|
218,582 | 92.2% |
P
S
|
455,660 | $20,987,700 | 2016 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AURA
AURA BIOSCIENCE...
|
Healthcare | 0.70% | 0.52% |
#40
12
Prev: #52
|
2.8 |
—
|
833,333 | 39.4% |
P
S
|
2,951,030 | $20,952,313 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
AGOMAB THERAPEU...
|
|
Unknown | 0.68% | 0.47% |
#41
19
Prev: #60
|
2.8 |
—
|
368,188 | 30.7% |
P
S
|
1,568,188 | $20,355,080 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 0.67% | 0.86% |
#42
12
Prev: #30
|
3.3 |
—
|
2,425,000 | 79.5% |
P
S
|
5,475,040 | $20,038,646 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BNTC
BENITEC BIOPHAR...
|
Healthcare | 0.66% | 0.56% |
#43
3
Prev: #46
|
0.8 |
—
|
50,000 | 3.5% |
P
S
|
1,488,371 | $19,914,404 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ADMA
ADMA BIOLOGICS ...
|
Healthcare | 0.66% | — |
#44
Prev: #—
|
3.8 |
—
|
2,359,993 | — |
NEW
|
2,359,993 | $19,753,141 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CWH
CAMPING WORLD H...
|
Consumer Cyclical | 0.65% | 0.82% |
#45
11
Prev: #34
|
0.3 |
—
|
-708,219 | -21.7% |
P
S
|
2,551,055 | $19,464,550 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 0.63% | 0.70% |
#46
6
Prev: #40
|
0.8 |
—
|
-86,237 | -4.3% |
P
S
|
1,901,160 | $19,011,600 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MDXG
MIMEDX GROUP IN...
|
Healthcare | 0.61% | 0.49% |
#47
9
Prev: #56
|
2.7 |
—
|
1,370,253 | 40.3% |
P
S
|
4,767,552 | $18,355,075 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 0.59% | 0.56% |
#48
1
Prev: #47
|
0.7 |
—
|
-3,478 | -2.5% |
P
S
|
133,759 | $17,824,724 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
USNA
USANA HEALTH SC...
|
Consumer Defensive | 0.58% | 0.52% |
#49
4
Prev: #53
|
1.2 |
—
|
no change | no change |
P
S
|
810,074 | $17,295,080 | 2012 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 0.53% | 0.39% |
#50
17
Prev: #67
|
1.2 |
—
|
no change | no change |
P
S
|
651,993 | $15,778,231 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 179 holdings